MoonLake Immunotherapeutics - Class A —— 现金流量表 (NASDAQ:MLTX) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 —-611.07 K-55.89 M-42.78 M-116.59 M-196.01 M -196.01 M 投资活动产生的现金 —0-32.34 M-25.18 M-205.6 M202.99 M 202.99 M 融资活动产生的现金 —-58.06 K119.69 M479.7 M51.31 M146 M 146 M 自由现金流 —-611.07 K-55.91 M-43.06 M-117.11 M-196.04 M -196.04 M

新闻

Clear Street上调Moonlake目标价,看好IL-17数据

Clear Street raises Moonlake stock price target on IL-17 data

Cantor Fitzgerald重申Moonlake股票评级,看好强直性脊柱炎市场潜力

Cantor Fitzgerald reiterates Moonlake stock rating on axSpA potential

H.C. Wainwright基于试验结果将Moonlake Immunotherapeutics目标价上调至40美元

Moonlake Immunotherapeutics stock price target raised to $40 by H.C. Wainwright on trial results

MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal (NASDAQ:MLTX)

MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day - Slideshow (NASDAQ:MLTX) 2026-02-23

MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript

MoonLake股价因axSpA试验数据积极而飙升

MoonLake stock surges on positive axSpA trial data

InvestingPro公允价值预测后MoonLake股价飙升63%